Sustained improvement in general health-related quality of life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 5-year data from clinical trial VOYAGE 2

被引:0
|
作者
Reich, Kristian [1 ]
Gordon, Kenneth B. [2 ]
Foley, Peter [3 ]
Lomaga, Mark [4 ]
Han, Chenglong [5 ]
Miller, Megan [6 ]
You, Yin [6 ]
Radtke, Marc Alexander [7 ]
Wu, Jashin J. [8 ]
Armstrong, April W. [9 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] Univ Melbourne, St Vincents Hosp Melbourne & Prob Med Res, Skin Hlth Inst, Melbourne, Vic, Australia
[4] DermEdge Res, Mississauga, ON, Canada
[5] Janssen Global Serv LLC, Raritan, NJ USA
[6] Janssen Res & Dev LLC, Raritan, NJ USA
[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[8] Dermatol Res & Educ Fdn, Irvine, CA USA
[9] Univ Southern Calif, Los Angeles, CA 90007 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
28096
引用
收藏
页码:AB174 / AB174
页数:1
相关论文
共 50 条
  • [1] Sustained improvement in general health-related quality life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 3-year data from clinical trial VOYAGE 2
    Reich, K.
    Gordon, K. B.
    Foley, P.
    Lomaga, M.
    Han, C.
    Song, M.
    Shen, Y. -K.
    Radtke, M. A.
    Wu, J. J.
    Armstrong, A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB280 - AB280
  • [2] Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2
    Reich, K.
    Gordon, K. B.
    Strober, B. E.
    Armstrong, A. W.
    Miller, M.
    Shen, Y. K.
    You, Y.
    Han, C.
    Yang, Y. W.
    Foley, P.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (06) : 1146 - 1159
  • [3] Maintaining long-term improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe plaque psoriasis treated with guselkumab: VOYAGE 2, 5-year data
    Armstrong, April W.
    Gordon, Kenneth B.
    Spelman, Lynda
    Papp, Kim A.
    Han, Chenglong
    Song, Michael
    You, Yin
    Puig, Luis
    Ferris, Laura K.
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB167 - AB167
  • [4] Health related quality of life and work productivity impairment among patients with moderate to severe psoriasis in Taiwan
    Huang, Yu-Huei
    Tsai, Tsen-Fang
    Ho, Yi-Chen
    Chen, Yi-Ju
    Wang, Michael Yao-Hsien
    Chu, Gong-Yau
    Wang, Tim Teng-Hsu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB55 - AB55
  • [5] Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate-to-severe psoriasis treated with guselkumab: 5-year data from VOYAGE 1
    Griffiths, Christopher E. M.
    Blauvelt, Andrew
    Han, Chenglong
    Fernandez-Penas, Pablo
    Adam, David N.
    Philipp, Sandra
    Song, Michael
    Miller, Megan
    You, Yin
    Langley, Richard G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB127 - AB127
  • [6] Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain
    Dauden, E.
    Vidal, D.
    Romero, A.
    Bordel, M. T.
    Rivera, R.
    Marquez, J.
    Zamora, E.
    Martinez, L.
    Ocana, M. J.
    Vila, C.
    Iribarren, P.
    Corona, N.
    Zulaica, A.
    ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (01): : 1 - 9
  • [7] Association between clinical response and health-related quality of life outcomes for patients with moderate to severe psoriasis
    Revicki, Dennis
    Menter, Alan
    Saurat, Jean
    Kaul, Martin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB128 - AB128
  • [8] Speed of improvement in genital psoriasis, genital itch, sexual impact, and health-related quality of life in patients with moderate to severe genital psoriasis treated with ixekizumab
    Merola, Joseph F.
    Guenther, Lyn
    Foley, Peter
    Burge, Russel
    See, Kyoungah
    McKean-Matthews, Missy
    Gallo, Gaia
    Ryan, Caitriona
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB19 - AB19
  • [9] Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis
    Schmitt, Jochen M.
    Ford, Daniel E.
    DERMATOLOGY, 2006, 213 (02) : 102 - 110
  • [10] The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials
    Armstrong, April
    Puig, Luis
    Papp, Kim A.
    Strauss, Marcie E.
    Yang, Ya-Wen
    Cheng, Ru-Fong
    Miller, Megan
    Murase, Jenny E.
    Fernandez-Penas, Pablo
    Han, Chenglong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB235 - AB235